What the policy lists
| Prior authorization | listed in the policy |
|---|
UnitedHealthcare's documents for Dupixent
What your plan's policy says
The plan's document holds the details for this medicine.
What this medicine is used for
“DUPIXENT is an interleukin-4 receptor alpha antagonist indicated”
“Atopic Dermatitis for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.”
“DUPIXENT can be used with or without topical corticosteroids.”
“Asthma as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma.”
“Not for the relief of acute bronchospasm or status asthmaticus.”
“Chronic Rhinosinusitis with Nasal Polyps as an add-on maintenance treatment in adult and pediatric patients aged 12 years and older with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP).”
“Eosinophilic Esophagitis for the treatment of adult and pediatric patients aged 1 year and older, weighing at least 15 kg, with eosinophilic esophagitis (EoE).”
“Prurigo Nodularis for the treatment of adult patients with prurigo nodularis (PN).”
“Chronic Obstructive Pulmonary Disease as an add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.”
“Not for the relief of acute bronchospasm.”
“Chronic Spontaneous Urticaria for the treatment of adult and pediatric patients aged 2 years and older with chronic spontaneous urticaria (CSU) who remain symptomatic despite H1 antihistamine treatment.”
“Not indicated for other forms of urticaria.”
“Bullous Pemphigoid for the treatment of adult patients with bullous pemphigoid (BP).”
“Atopic Dermatitis DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.”
From the FDA label for Dupixent, revised April 22, 2026. The label is shown in English as published. DailyMed. Your doctor decides what it is used for in your case.
Common questions
Does UnitedHealthcare require prior authorization for Dupixent?
UnitedHealthcare's published policy lists prior authorization for Dupixent.
How do I see the policy for my own plan and state?
Open the free KAIS guide, pick your plan, your type of plan, your state and your medicine, and it shows the policy your plan publishes, with the link to the plan's own document.
Not medical advice and not a decision on your claim. Your doctor and your plan decide.